Cambridge, MA, United States of America

Monika S Kowalczyk

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Monika S Kowalczyk: Innovator in Innate Lymphoid Cell Research

Introduction

Monika S Kowalczyk is a prominent inventor based in Cambridge, MA, known for her significant contributions to the field of immunology. She has been awarded two patents that focus on modulating innate lymphoid cell (ILC) responses, which play a crucial role in inflammation and allergic reactions. Her work has implications for treating various inflammatory conditions, including skin disorders like psoriasis.

Latest Patents

Kowalczyk's latest patents include "Methods and compositions for modulating innate lymphoid cell pathogenic effectors" and "Methods and compositions for regulating innate lymphoid cell inflammatory responses." The first patent addresses methods for modulating inflammation driven by the differentiation of quiescent tissue-resident ILCs into pathogenic effectors. It also covers the detection and monitoring of ILC responses, with a focus on treating skin inflammation. The second patent highlights the role of the neuropeptide receptor Nmur1 in Type 2 innate lymphoid cells (ILC2s) and its impact on allergic lung inflammation. The findings demonstrate how Nmur1 signaling modulates IL-25-mediated ILC2 responses, emphasizing the importance of neuro-immune interactions in allergic inflammatory responses.

Career Highlights

Throughout her career, Kowalczyk has worked with esteemed institutions such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. Her research has significantly advanced the understanding of innate lymphoid cells and their role in immune responses.

Collaborations

Kowalczyk has collaborated with notable colleagues, including Samantha J Riesenfeld and Aviv Regev, contributing to a rich exchange of ideas and research advancements in her field.

Conclusion

Monika S Kowalczyk's innovative work in innate lymphoid cell research has the potential to transform approaches to treating inflammatory diseases. Her patents reflect a deep understanding of immune mechanisms and highlight her role as a leading inventor in this critical area of study.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…